William Hartzel - 06 Mar 2025 Form 4/A - Amendment Insider Report for Emergent BioSolutions Inc. (EBS)

Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
06 Mar 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
09 Apr 2025, 18:31:16 UTC
Date Of Original Report
10 Mar 2025
Previous filing
07 Mar 2025
Next filing
09 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Award $0 +62,500 +132% $0.000000 109,683 06 Mar 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the day prior to the anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
F2 This Form 4/A is filed solely to correct the previously reported amount of securities beneficially owned following the reported transaction. The original Form 4 filing reported 109,975 due to a clerical error.